Annals of Clinical Biochemistry International Journal of Laboratory Medicine · 2005 · 42 citations · 4 references
PharmacyBiochemistryAnalytical ChemistryDiabetologyGood Laboratory PracticeBioanalytical Method ValidationDiabetes MellitusReference Product ComparisonReference Product SelectionTest Product ComparisonClinical Chemistry AssaysClinical Chemistry Laboratory RegulationHemoglobin A1c TestingHemoglobin LevelsLaboratory TestingReference Laboratory StandardsReference Material ComparisonReference Material Development
BACKGROUND: The Committee on Standardization of Laboratory Testing Related to Diabetes Mellitus of the Japan Diabetes Society (JDS) previously recommended use of the primary calibrator (JDS Lot 1) prepared by the former Committee for Standardization of Glycohemoglobin for standardizing the measurement of haemoglobin A1c (HbA1c). Owing to the depletion of vials of Lot 1 in March 2001, the present committee certified a new reference material, Lot 2, now distributed by the Health Care Technology Foundation (HECTEF). The standardization programme for HbA1c measurement in Japan is currently based on Lot 2, which has values assigned from within Lot 1; the Lot 1 values were consensus values based on assays by laboratories in the Japanese national quality control programme. In this study, for the purpose of international comparison and standardization, Lot 2 was assayed by the JDS reference laboratories, the National Glycoprotein Standardization Program (NGSP) in the USA, and by reference laboratories approved by the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC). METHOD: The HbA1c values of JDS Lot 2 were transferred from those assigned to Lot 1 using KO500, a high-resolution HPLC method, at three laboratories approved by the JDS committee. Subsequently, vials of JDS Lot 2 were shipped to and assayed by the NGSP in the USA and 10 IFCC reference laboratories. RESULT: The JDS-assigned HbA1c values (from Lot 1) are 4.04 for Level 1, 5.38 for Level 2, 7.32 for Level 3, 9.88 for Level 4, and 12.63 for Level 5, all expressed as a percentage of total haemoglobin. The values obtained by NGSP and the IFCC laboratories gave the following formulas: NGSP value(%)=JDS value(%)+0.3%; IFCC value(%)=1.068xJDS value(%)-1.741%. CONCLUSION: Although the values obtained by the IFCC laboratories are significantly lower than the values assigned to Lot 2 by the JDS, the relationship is linear. In addition, standardization of HbA1c based on JDS Lot 2 is currently at a satisfactory level in Japan. As a result, the reassignment of values for Lot 2 to agree with the IFCC values should be relatively easy and will be done after all relevant parties agree to the change.
4
Wieland Hoelzel, Cas Weykamp, Jan‐Olof Jeppsson et al. · Clinical Chemistry · 2004 · 695 citations
The national glycohemoglobin standardization program: a five-year progress report.
Randie R. Little, Curt L. Rohlfing, Hsiao-Mei Wiedmeyer et al. · PubMed · 2001 · 345 citations
Candidate reference methods for hemoglobin A1c based on peptide mapping
Uwe Kobold, Jan‐Olof Jeppsson, Thomas Dülffer et al. · Clinical Chemistry · 1997 · 182 citations
Pharmacy, Biochemistry, Hematology +17